Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Kabraji · SciRah

Researcher profile · Semantic Scholar

S. Kabraji

Share profile

S. Kabraji — researcher profile on SciRah

h-index: 16
Works: 58
Citations: 1,421

Most-cited papers

ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer
J. Gainor, A. Varghese, S. Ou, S. Kabraji +12 more
2013Clinical Cancer Research576 citations Open access
Semantic Scholar
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer
Qi-Wei Wang, J. Bergholz, L. Ding, Zi-Ying Lin +15 more
2022Nature Communications233 citations Open access
Semantic Scholar
PI3Kβ controls immune evasion in PTEN-deficient breast tumors
J. Bergholz, Qi-Wei Wang, Qi Wang, Michelle L. Ramseier +18 more
2023Nature105 citations Open access
Semantic Scholar
Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain?
S. Kabraji, Jing Ni, N. Lin, Shao-Zhen Xie +2 more
2018Clinical Cancer Research79 citations Open access
Semantic Scholar
Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases
S. Kabraji, Jing Ni, S. Sammons, Tian-Yu Li +15 more
2022Clinical Cancer Research68 citations Open access
Semantic Scholar
Integrating immunotherapy and targeted therapy in cancer treatment: mechanistic insights and clinical implications
J. Bergholz, Qi-Wei Wang, S. Kabraji, Jean J. Zhao
2020Clinical Cancer Research48 citations Open access
Semantic Scholar
JARID1B enables transit between distinct states of the stem-like cell population in oral cancers
Nicole D. Facompre, Kayla M. Harmeyer, X. Solé, S. Kabraji +13 more
2016Cancer Research48 citations Open access
Semantic Scholar
Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method
Zong-Ming Liu, Yanzhi Wang, S. Kabraji, Shao-Zhen Xie +4 more
2019Scientific Reports33 citations Open access
Semantic Scholar
AKT1low quiescent cancer cells persist after neoadjuvant chemotherapy in triple negative breast cancer
S. Kabraji, X. Solé, Ying Huang, C. Bango +5 more
2017Breast Cancer Research22 citations Open access
Semantic Scholar
Temporal and spatial topography of cell proliferation in cancer
Giorgio Gaglia, S. Kabraji, Danae Rammos, Yang Dai +14 more
2022Nature Cell Biology21 citations Open access
Semantic Scholar
p16INK4A-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases
Jing Ni, S. Kabraji, Shao-Zhen Xie, Yanzhi Wang +10 more
2022Nature Communications21 citations Open access
Semantic Scholar
Temporal and spatial topography of cell proliferation in cancer
S. Kabraji, Giorgio Gaglia, Danae Argyropoulou, Yang Dai +11 more
2021bioRxiv21 citations Open access
Semantic Scholar
AKT1low quiescent cancer cells promote solid tumor growth
C. P. Alves, I. Dey-Guha, S. Kabraji, Albert C. Yeh +10 more
2017Molecular Cancer Therapeutics21 citations Open access
Semantic Scholar
Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancer
S. Sherman, Zachary M. Sandusky, D. Russo, D. Zak +12 more
2025JCI Insight18 citations Open access
Semantic Scholar
Estrogen Signaling in Early-Stage Breast Cancer: Impact on Neoadjuvant Chemotherapy and Immunotherapy.
C. Corti, Busem Binboğa Kurt, B. Koca, Tasnim Rahman +10 more
2024Cancer Treatment Reviews17 citations Open access
Semantic Scholar
Abstract 4: Temporal and spatial topography of cell proliferation in cancer
Giorgio Gaglia, S. Kabraji, Danae Argyropoulou, Yang Dai +8 more
2021Bioinformatics and Systems Biology16 citations
Semantic Scholar
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis
R. Bartsch, J. Pérez-García, J. Furtner, A. Berghoff +18 more
2025ESMO Open13 citations Open access
Semantic Scholar
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
Erik S. Knudsen, A. Witkiewicz, S. Kabraji
2026Nature reviews. Drug discovery7 citations
Semantic Scholar
RAS/RAF co-mutation and ERBB2 copy number modulates HER2 heterogeneity and responsiveness to HER2-directed therapy in colorectal cancer
Harshabad Singh, P. Sahgal, Kevin S. Kapner, Steven M. Corsello +38 more
2024Clinical Cancer Research7 citations Open access
Semantic Scholar
Keeping it in the family: HER3 as a target in brain metastases.
S. Kabraji, N. Lin
2023Clinical Cancer Research6 citations
Semantic Scholar
Abstract PD4-05: Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases (BCBM)
S. Kabraji, Jing Ni, S. Sammons, A. V. Van Swearingen +13 more
2022Cancer Research6 citations
Semantic Scholar
AKT1low quiescent cancer cells in ductal carcinoma in situ of the breast
S. Kabraji, X. Sole, Ying Huang, C. Bango +3 more
2019npj Breast Cancer6 citations Open access
Semantic Scholar
Mechanism of Inhibitory Action of Cyclooxygenase-2 Inhibitors in Human Platelets
S. A. Saeed, H. Rasheed, T. M. Ali, Y. Qazi +5 more
20046 citations Open access
Semantic Scholar
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
A. Grinshpun, D. Russo, Wen Ma, A. Verma +14 more
2024npj Breast Cancer4 citations Open access
Semantic Scholar
Causal multi-modal AI for personalized chemosensitivity prediction
D. Biswas, Jeroen Berrevoets, A. McClean, L. Bao +30 more
20263 citations
Semantic Scholar
Real world plasma thymidine kinase activity in high-risk and metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with cyclin-dependent kinase 4/6 inhibitors
Thomas N. O'Connor, E. Schultz, S. Kabraji, E. Levine +3 more
2026JCO Precision Oncology3 citations
Semantic Scholar
Abstract HER2-05: HER2-05 Comprehensive genomic characterization of HER2-low breast cancer
P. Tarantino, H. Gupta, M. Hughes, J. Files +22 more
2023Cancer Research3 citations
Semantic Scholar
THER-12. PRECLINICAL EVALUATION OF NERATINIB PLUS T-DM1 IN ORTHOTOPIC PDX MODELS OF HER2-POSITIVE BREAST CANCER BRAIN METASTASES
Jing Ni, Yanzhi Wang, I. Diala, S. Kabraji +3 more
2019Neuro-Oncology Advances3 citations Open access
Semantic Scholar
Abstract 4832: Preclinical evaluation of neratinib plus T-DM1 in orthotopic PDX models of HER2-positive breast cancer brain metastases
Jing Ni, Yanzhi Wang, I. Diala, S. Kabraji +3 more
2019Experimental and Molecular Therapeutics2 citations
Semantic Scholar
Real-world analysis of adjuvant abemaciclib in high-risk HR+/HER2− early breast cancer.
Mariam Haji, Z. Shah, Han Yu, S. Kabraji
2026Journal of Clinical Oncology1 citations Open access
Semantic Scholar
GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: A real-world analysis.
Z. Shah, J. Hundal, S. Afridi, Sumbal Aziz +6 more
2026Journal of Clinical Oncology1 citations
Semantic Scholar
Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.
Z. Shah, L. Lei, R. Thakur, Ajinkya Buradkar +12 more
2026Journal of the National Cancer Institute1 citations
Semantic Scholar
Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from breast cancer.
S. Gandhi, P. Forsyth, Mateusz Opyrchal, A. Rawleigh +11 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Abstract PS14-07: Spatial transcriptomics of matched breast cancer brain metastases and primary tumors identifies a brain-specific immune-suppressive transcriptional program
P. Kurnia, S. Kabraji, B. Kurt, Maria-Anna Chrysovergi +3 more
2025Clinical Cancer Research1 citations
Semantic Scholar
Racial disparities in clinical outcomes of early-stage triple-negative breast cancer treated with neoadjuvant chemoimmunotherapy: Insights from the NCDB.
Z. Shah, S. Afridi, M. Samejo, Mrinalini Ramesh +12 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Genomic profiling of breast cancer brain metastases reveals targetable alterations.
S. Kabraji, L. Spurr, M. Hughes, Yvonne Y. Li +9 more
2020Journal of Clinical Oncology1 citations
Semantic Scholar
Persistence of AKT1 low quiescent cancer cells after neoadjuvant chemotherapy in triple negative breast cancer patients.
S. Kabraji, X. Solé, Ying Huang, C. Bango +5 more
20171 citations
Semantic Scholar
A retrospective analysis of the prevalence of EGFR or KRAS mutations in patients (pts) with crizotinib-naïve and crizotinib-resistant, ALK-positive non-small cell lung cancer (NSCLC).
J. Gainor, A. Varghese, S. Ou, S. Kabraji +12 more
20131 citations
Semantic Scholar
Predictive Biomarkers and Personalized Medicine ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS : An Analysis of 1 , 683 Patients with Non – Small Cell Lung Cancer
J. Gainor, A. Varghese, S. Ou, S. Kabraji +12 more
20131 citations
Semantic Scholar
Real-world brain metastasis outcomes with T-DXd versus tucatinib-based therapy in second-line HER2-positive metastatic breast cancer.
Z. Shah, Han Yu, S. Afridi, S. Yao +2 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract PS5-08-09: A Pilot, Single-Arm, Phase II Trial of Tamoxifen plus Pegylated Liposomal Doxorubicin in Patients with Metastatic Triple Negative Breast Cancer
Z. Shah, C. Oturkar, I. Aijaz, H. Yu +3 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Abstract PS4-03-20: Spatial and biomarker associations of CD83, a promising CAR-T target for breast cancer
M. Homsi, M. Davila, R. Brentjens, B. Betts +1 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Standardized exam-style benchmarking of large language models in breast cancer clinical decision-making.
Mariam Haji, Z. Shah, Han Yu, S. Kabraji
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract PS2-11-14: Residual disease after trastuzumab deruxtecan treatment of HER2+ breast tumors is promoted by leucyl tRNA synthetase 2 (LARS2) in HER2-low tumor cells
V. Kurisetty, M. Homsi, S. Kabraji
2026Clinical Cancer Research0 citations
Semantic Scholar
Real-World Brain Metastasis Outcomes with T-DXd Versus Tucatinib-Based Therapy in Second-Line HER2-Positive Metastatic Breast Cance
Z. Shah, S. Kabraji
2026American Medical Journal Oncology0 citations Open access
Semantic Scholar
Abstract PS4-09-04: Global disparities in breast cancer clinical trials and their impact on clinical evidence, driven by underrepresentation of low- and middle-income countries
V. Gupta, V. Singh, M. Alharbi, N. Sharma +4 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Abstract 1303: Real-world overall survival with trastuzumab deruxtecan versus standard chemotherapy in HER2-amplified MSS metastatic colorectal cancer.
Sumbal Aziz, Z. Shah, Maria Ahmad, Jayasree Krishnan +4 more
2026Cancer Research0 citations
Semantic Scholar
Real-world incidence, prevalence, and short-term outcomes in young-onset breast cancer.
S. Afridi, Su-Su Zhou, Sumbal Aziz, Nuri Tamanna +4 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract PS3-04-06: Benchmarking Large Language Models for Clinical Decision Support in Breast Cancer Care: A Multi-Institutional Expert Evaluation
Z. Shah, S. Afridi, M. Ombada, A. Roy +17 more
2026Clinical Cancer Research0 citations
Semantic Scholar
Pathologic complete response to neoadjuvant targeted therapy in locally advanced invasive lobular breast cancer
Nouman Aziz, S. Makhkamov, M. Desouki, Prasanna Kumar +1 more
2026npj Precision Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Lin×11
Invite
N. Lin — researcher profile on SciRah
Jean J. Zhao×11
Invite
Jean J. Zhao — researcher profile on SciRah
Z. Shah×11
Invite
Z. Shah — researcher profile on SciRah
Jing Ni×7
Invite
Jing Ni — researcher profile on SciRah

×6

Invite

E. Winer — researcher profile on SciRah

Invite

Yanzhi Wang — researcher profile on SciRah

R. Jeselsohn×6

Invite

R. Jeselsohn — researcher profile on SciRah

Invite

S. Gandhi — researcher profile on SciRah

Invite

J. Bergholz — researcher profile on SciRah

Invite

M. Hughes — researcher profile on SciRah

Shao-Zhen Xie×5

Invite

Shao-Zhen Xie — researcher profile on SciRah

S. Ramaswamy×5

Invite

S. Ramaswamy — researcher profile on SciRah